Literature DB >> 11776122

Cerebral venous sinus thrombosis: a clinical study of 23 cases.

Z Zhang1, J Long, W Li.   

Abstract

OBJECTIVE: To describe the etiologies, clinical features and diagnosis of cerebral venous sinus thrombosis.
METHODS: We reviewed the records of 23 patients admitted with a documented diagnosis of cerebral venous sinus thrombosis from 1991 through 1999 in the Beijing Tiantan Hospital.
RESULTS: Infection was the major condition associated with cerebral venous sinus thrombosis. Pseudotumor cerebri syndrome was the most common manifestation, while hemiplegia, seizure and unconsciousness may occur alone or in association. The diagnostic sensitivity of computed tomography (CT), magnetic resonance imaging (MRI) and digital subtract angiography (DSA) were 59%, 86% and 100%, respectively. The sensitivity of MRI with magnetic resonance angiography (MRA) reached 96%.
CONCLUSION: As the clinical findings were found to be nonspecific, CT combined with DSA, or MRI with MRA turns out to be valuable for the early diagnosis of cerebral venous sinus thrombosis.

Entities:  

Mesh:

Year:  2000        PMID: 11776122

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Pseudotumor cerebri: a new door opens for treatment.

Authors:  R Crosa; O Marabotto; G Meehroff; C Legnani; J Boschi; A Negrotto; K G Terbrugge; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2007-09-13       Impact factor: 1.610

2.  Thrombosis of sinus sagitalis during puerperium caused by thrombophilic gene mutation.

Authors:  Marina Titlic; Sanda Pavelin; Ante Tonkic; Ivana Jukic; Ante Buca; Simun Andelinovic
Journal:  J Thromb Thrombolysis       Date:  2007-06-16       Impact factor: 2.300

3.  Cerebral venous thrombosis: a Moroccan retrospective study of 30 cases.

Authors:  Zouhayr Souirti; Ouafae Messouak; Faouzi Belahsen
Journal:  Pan Afr Med J       Date:  2014-04-14

4.  Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data.

Authors:  Hikmat Abdel-Razeq; Baha' Sharaf; Rama AlMasri; Rashid Abdel-Razeq; Faris Tamimi; Omar Khader; Osama Salama; Mahmoud Abunasser; Sarah Edaily; Hazem Abdulelah
Journal:  Cancer Manag Res       Date:  2022-03-08       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.